Home
>
National Drug Code (NDC)
>
benzonatate
benzonatate - 67877-105-10 - (benzonatate)
Drug Information of benzonatate
| Product NDC: | 67877-105 |
| Proprietary Name: | benzonatate |
| Non Proprietary Name: | benzonatate |
| Active Ingredient(s): | 100 mg/1 & nbsp; benzonatate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of benzonatate
| Product NDC: | 67877-105 |
| Labeler Name: | Ascend Laboratories LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040627 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070725 |
Package Information of benzonatate
| Package NDC: | 67877-105-10 |
| Package Description: | 1000 CAPSULE in 1 BOTTLE (67877-105-10) |
NDC Information of benzonatate
| NDC Code | 67877-105-10 |
| Proprietary Name | benzonatate |
| Package Description | 1000 CAPSULE in 1 BOTTLE (67877-105-10) |
| Product NDC | 67877-105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | benzonatate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070725 |
| Marketing Category Name | ANDA |
| Labeler Name | Ascend Laboratories LLC |
| Substance Name | BENZONATATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |
